We have demonstrated that β2-AR activation by salmeterol leads to a reduction in the proliferation, myofibroblastic differentiation and CCR7 expression in fibrocytes from healthy subjects and patients with non-severe asthma. The gene discussed is ADRB2; the disease is asthma.